PVXL
LIVE

Serial Number

79368657

Owner

POPVAX PRIVATE LIMITED

Attorney

Lauren K. Tagarao

Filing Date

Nov 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PVXL Trademark

Serial Number: 79368657 • Registration: 7741388

PVXL is a trademark filed by POPVAX PRIVATE LIMITED on November 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

POPVAX PRIVATE LIMITED (14 trademarks)

8c lohtse chs, millitary road,

Entity Type: 99

Trademark Details

Filing Date

November 10, 2022

Registration Date

April 1, 2025

Published for Opposition

February 11, 2025

Goods & Services

Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; clinical trials and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; Software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations, Software as a service (SaaS) services featuring computer software for controlling, optimization, calibration, maintenance, diagnostics, and troubleshooting of bioprocess systems, equipments, tools, and apparatus namely mixing devices, microfluidic devices, micro-mixing devices, mixing vessels, filtration systems, fermenters or bioreactors, liquid handling systems, separation systems, purification systems, chromatography systems, formulation systems, analytical systems, characterization systems, filling system, lyophilisation system, spray drying system, encapsulation system, pumps, pressure vessels, sensors, actuators, flow controllers, control system for fluidics, automated control systems, robotic systems, synthesis systems, and thermocyclers, Software as a service (SaaS) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management; creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring information in the pharmaceutical, medical and health fields; hosting a website featuring non-downloadable podcasts in the field of pharmaceutical, medical and health fields.

Pharmaceutical and medical preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; pharmaceuticals, medical and veterinary preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for medical purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for veterinary purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for pharmaceutical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; diagnostic preparations for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; drugs for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; medicines for human purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; vaccines for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, and reproductive disorders; medical, biological and pharmaceutical preparations containing nucleic acids or proteins for the prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, and reproductive disorders; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutic for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose

Equipments, tools, apparatus used in the manufacturing of pharmaceutical, medicinal and biological preparations, nucleic acid vaccines and therapeutics, namely, mixing devices in the nature of mixing machines, and crossflow mixing machines, microfluidic devices in the nature of microfluidic pumps, microfluidic valves, microfluidic actuators, microchannels, microwells, straight channel microfluidic device, Y channel microfluidic device, T junction microfluidic device, cross junction microfluidic device, and crossflow microfluidic device, micro-mixing devices in the nature of micro-mixing machines, and crossflow micro-mixing machines, mixing vessels, filtration systems comprising machines used for process filtration, bioreactors, power-operated liquid handling systems comprising tank, pump, syringes and sprayer, separation systems comprising separating machines for chemical or biological sample processing, formulation systems comprising vessels, stirrers, filters, heating or cooling jackets, dispensers, pumps, flow meters and cartridges, filling systems comprising filling machines, spray drying systems comprising chemical fiber drying machines, encapsulation systems comprising pharmaceutical production machines for producing nanoparticles, microparticles, lipid nanoparticles, liposomes, micelles, gels, emulsions, hard gelatin capsules, pumps in the nature of turbomolecular pumps, centrifugal pumps, peristaltic pumps, diaphragm pumps , high-pressure vessels being machine components, namely, pressure regulators being parts of machines, hydraulic valve actuators, robotic systems comprising industrial robots, and thermocyclers; machines for pharmaceutical processing industry, namely, mixing devices in the nature of mixing machines and crossflow mixing machines, microfluidic devices in the nature of microfluidic pumps, microfluidic valves, microfluidic actuators, microchannels, microwells, straight channel microfluidic device, Y channel microfluidic device, T junction microfluidic device, cross junction microfluidic device, and crossflow microfluidic device, micro-mixing devices in the nature of micro-mixing machines and crossflow micro-mixing machines, mixing vessels, filtration systems comprising machines used for process filtration, bioreactors, power-operated liquid handling systems comprising tank, pump, syringes and sprayer, separation systems comprising separating machines for chemical or biological sample processing, formulation systems comprising vessels, stirrers, filters, heating or cooling jackets, dispensers, pumps, flow meters and cartridges, filling systems comprising filling machines, spray drying systems comprising chemical fiber drying machines, encapsulation systems comprising pharmaceutical production machines for producing nanoparticles, microparticles, lipid nanoparticles, liposomes, micelles, gels, emulsions, hard gelatin capsules, pumps in the nature of turbomolecular pumps, centrifugal pumps, peristaltic pumps, diaphragm pumps, high-pressure vessels being machine components, namely, pressure regulators being parts of machines, hydraulic valve actuators, robotic systems comprising industrial robots, and thermocyclers.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 31, 2025 FINO
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Oct 21, 2025 NURC
FINAL DISPOSITION NOTICE SENT TO IB
Oct 9, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 8, 2025 FIMP
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 2, 2025 COC.
POST REGISTRATION ACTION MAILED - SEC. 7
Sep 30, 2025 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 22, 2025 APRE
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 1, 2025 FICR
TEAS SECTION 7 REQUEST RECEIVED
Jun 18, 2025 ES7R
POST PUBLICATION AMENDMENT – NOT ENTERED
Apr 2, 2025 CHPN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 1, 2025 NRCC
ASSIGNED TO PETITION STAFF
Apr 1, 2025 APET
ASSIGNED TO PETITION STAFF
Apr 1, 2025 APET
REGISTERED-PRINCIPAL REGISTER
Apr 1, 2025 R.PR
TEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 25, 2025 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 13, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 19, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 2, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 14, 2024 GNFN
FINAL REFUSAL E-MAILED
May 14, 2024 GNFR
FINAL REFUSAL WRITTEN
May 14, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 11, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 15, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 15, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 27, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 24, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 9, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 4, 2023 REPR